Journal: bioRxiv
Article Title: CAR T cells targeting Nectin-4 safely overcome resistance to anti-Nectin-4 antibody-drug conjugate in solid tumors
doi: 10.1101/2025.09.30.679440
Figure Lengend Snippet: A. Nectin-4 expression on three cell lines in comparison with SUM190PT. B. MCF7, HT29, RT112 and SUM190PT cell lines were treated with CD30-MMAE(negative control) and enfortumab vedotin. MCF7, HT29 and RT112 cell lines are resistant to enfortumab vedotin whereas SUM190PT is sensible. n = 2 biologic replicates were examined in one experiment. C . 4-hour caspase 3/7 cytotoxicity assay indicating a tumor killing of CARTN4 cells against MCF7, HT29, RT112. n=4 healthy donors were examined in three independent experiments. Data in panels B, and C are presented as Mean +/- SEM. P-values were calculated using a 2way ANOVA. Source data are provided in the Source Data file.
Article Snippet: RT112 cell line was purchased from DSMZ Cell Dive (Braunschweig, Germany).
Techniques: Expressing, Comparison, Negative Control, Cytotoxicity Assay